Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Form 8 (OPD) - Redcentric PLC

3 Sep 2020 13:15

RNS Number : 9818X
Macquarie Group Ltd
03 September 2020
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Macquarie Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

Β 

Macquarie Principal Finance Pty Limited, UK Branch

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Β 

Redcentric PLC

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

No positions held

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

-

-

-

-

(2) Cash-settled derivatives:

Β 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

Β 

TOTAL:

0

0

0

0

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

N/A

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

N/A

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

3rd September 2020

Contact name:

Ruban Pillai

Telephone number:

+44 75 8461 6608

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FEEUPUCGBUPUGPW
Date   Source Headline
12th May 20203:22 pmRNSHolding(s) in Company
3rd Apr 20207:01 amRNSBoard Changes
3rd Apr 20207:00 amRNSTrading update and COVID-19 update
19th Mar 20205:48 pmRNSTransaction in Own Shares
17th Mar 20205:41 pmRNSTransaction in Own Shares
16th Mar 20205:15 pmRNSTransaction in Own Shares
27th Feb 20207:00 amRNSTransaction in Own Shares
13th Jan 20207:00 amRNSChange of Adviser
28th Nov 20197:00 amRNSHalf Year Results
20th Nov 20195:06 pmRNSTransaction in Own Shares
5th Nov 20195:02 pmRNSTransaction in Own Shares
30th Oct 20195:18 pmRNSTransaction in Own Shares
29th Oct 20197:00 amRNSTransaction in Own Shares
25th Oct 20195:23 pmRNSTransaction in Own Shares
17th Oct 20197:00 amRNSBoard Changes
9th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding and Issue of Equity
27th Sep 20195:57 pmRNSTransaction in Own Shares
17th Sep 20197:00 amRNSShare Buyback Programme
4th Sep 20192:30 pmRNSIssue of Options
2nd Sep 20191:03 pmRNSResult of AGM
30th Aug 20194:27 pmRNSDirector Shareholding
30th Aug 20194:19 pmRNSSave As You Earn Share Option Scheme
20th Aug 201911:00 amRNSDirectorate Change
14th Aug 20197:00 amRNSExercise of Options
2nd Aug 20197:00 amRNSPublication of Annual Report and Notice of AGM
17th Jul 20193:48 pmRNSDividend Dates
17th Jul 20197:00 amRNSChange of Dividend Dates
1st Jul 20193:58 pmRNSIssue of Options
25th Jun 20197:00 amRNSPreliminary Results Announcement FY19
28th May 20197:00 amRNSDirectorate Change
15th Apr 20197:00 amRNSTrading update and notice of results date
26th Feb 20192:58 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSDirectorate Change
5th Dec 20184:01 pmRNSDirector/PDMR Shareholding
28th Nov 20183:12 pmRNSHolding(s) in Company
27th Nov 20183:31 pmRNSHolding(s) in Company
22nd Nov 20187:01 amRNSDirectorate Change
22nd Nov 20187:00 amRNSHalf-year Report
19th Nov 20182:00 pmRNSHolding(s) in Company
4th Oct 20187:00 amRNSPre-Close Statement
3rd Sep 20186:05 pmRNSResult of AGM
9th Aug 201811:52 amRNSPublication of Annual Report and Notice of AGM
13th Jul 201810:14 amRNSHolding(s) in Company
12th Jul 20185:01 pmRNSHolding(s) in Company
5th Jul 20182:45 pmRNSHolding(s) in Company
28th Jun 20187:00 amRNSPreliminary Results Announcement FY18
26th Jun 20185:03 pmRNSHolding(s) in Company
8th Jun 20182:50 pmRNSTrading update
26th Apr 20187:00 amRNSAward of public sector framework agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.